Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2000

View Archived Issues

Intensive therapy offers persistent benefits in type I diabetes

Large valsartan trial reaches enrollment objectives

Alexion makes significant progress over past six months in various development programs

Vertex enters genomic partnership with Incyte

IL-4 gene therapy studied in malignant glioma

Rebif long-term data confirm dose-related efficacy; Ares-Serono to enhance labeling

CryoLife and Viragen enter cancer therapy collaboration

Ampakine-like compounds and their use described by Lilly

Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity

Guilford to develop novel propofol prodrug discovered by ProQuest

MMP inhibitors from Warner-Lambert particularly active against MMP-2, MMP-3 and MMP-13

International team provides new insight into the mechanics of HIV infection

Pharmaceutically useful neuroprotective agents emerge from R&D at Cambridge NeuroScience

ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis

U.S./Russian investigators present anesthetics with useful hypometabolic, cardiovascular effects

Estrogen protects against brain damage from ischemic insult in female rats

New vitamin D4 metabolite claimed by Bone Care for vitamin D-deficient states

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

Induction therapy with daclizumab in cardiac transplant recipients safe and effective

Actonel to be approved in Europe for Rx of postmenopausal osteoporosis

EpiGenesis and Taisho sign binding letter of intent for EPI-2010

Potent factor XIIIa inhibitor synthesized from naturally occurring cyclopropenones

Collaboration between Novartis and Emisphere extended to include second compound

Progenics announces important discoveries related to HIV fusion inhibitors

Triapine anticancer therapy completes phase I trial

Novantrone moves one step closer to approval for MS

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...